NDC 44567-501-02 - Levetiracetam
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 44567-501
- Requested NDC
- 44567-501-02
- Package NDCs from labels
- 44567-501-01, 44567-501-10, 44567-501-02, 44567-501-90
- Manufacturer
- WG Critical Care, LLC
- Effective date
- 2024-03-29
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Levetiracetam - WG Critical Care, LLC | WG Critical Care, LLC | 2024-03-29 | HUMAN PRESCRIPTION DRUG LABEL |
| Levetiracetam - WG Critical Care, LLC | WG Critical Care, LLC | 2023-10-30 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 44567-501-01 | Levetiracetam | 100 mL in 1 BAG | INJECTION | 100 | 6 | |
| 44567-501-10 | Levetiracetam | 10 in 1 CARTON | INJECTION | 10 | 6 | |
| 44567-501-02 | Levetiracetam | 100 mL in 1 BAG | INJECTION | 100 | 3 | |
| 44567-501-90 | Levetiracetam | 10 in 1 CARTON | INJECTION | 10 | 3 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 44567-501 | LEVETIRACETAM INJECTION [WG CRITICAL CARE, LLC] | 5 | Current NDC, Legacy NDC, 2 package rows | 20240601_62f3d1c8-ca5b-4760-9fc9-41e4fb4cc926.zip |
| 44567-501 | LEVETIRACETAM INJECTION [WG CRITICAL CARE, LLC] | 3 | Current NDC, Legacy NDC, 2 package rows | 20240113_5e5b0ed3-b104-45a7-bb3e-ee56febb46e8.zip |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 44567-501-01 | ML - Milliliter | 44567-501 | 9e2d0692-78d1-449a-9b18-1555c0c12a1b | 1 | 2022-07-06 |
| 44567-501-02 | ML - Milliliter | 44567-501 | 99ebf4bb-00a7-4827-b7a9-becb303cd0f8 | 1 | 2023-06-06 |
| 44567-501-10 | ML - Milliliter | 44567-501 | cff2ee94-7849-4182-85fb-4dd98195753d | 1 | 2022-06-06 |
| 44567-501-90 | ML - Milliliter | 44567-501 | 080c3ef7-7acd-460a-a666-737f289d63c7 | 1 | 2023-06-06 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Hypertonic Saline | SODIUM CHLORIDE | NAVEH PHARMA (1996) LTD | 167c7a9c-1228-4fb2-a89c-d3e148386323 | 2026-07-30 | Warnings | 451W47IQ8X |
| Hypertonic Saline Solution Sodium Chloride | SODIUM CHLORIDE | NAVEH PHARMA (1996) LTD | 750ea4b1-de2b-4299-aaa2-331daf383d0d | 2026-07-30 | Warnings | 451W47IQ8X |
| DECONIMO Reconstitution | DECONIMO RECONSTITUTION | Image Amazon LLC | 57ab9b1c-9a18-3786-e063-6394a90a2c63 | 2026-07-28 | Warnings | 059QF0KO0R |
| DELFLEX | DEXTROSE MONOHYDRATE, SODIUM CHLORIDE, SODIUM LACTATE, CALCIUM CHLORIDE, MAGNESIUM CHLORIDE | Fresenius Medical Care Renal Therapies Group, LLC | bbc5b820-4973-11e2-a192-0002a5d5c51b | 2026-07-27 | Warnings, Adverse reactions | 451W47IQ8X |
| DELFLEX | DEXTROSE MONOHYDRATE, SODIUM CHLORIDE, SODIUM LACTATE, CALCIUM CHLORIDE, MAGNESIUM CHLORIDE | Fresenius Medical Care Renal Therapies Group, LLC | c29bdfa0-4976-11e2-939b-0002a5d5c51b | 2026-07-27 | Warnings, Adverse reactions | 451W47IQ8X |
| Delflex | DEXTROSE MONOHYDRATE, SODIUM CHLORIDE, SODIUM LACTATE, CALCIUM CHLORIDE, MAGNESIUM CHLORIDE | Fresenius Medical Care de Mexico, S.A. de C.V. | a98facd6-9daa-4d37-8209-63a0599dbfaa | 2026-07-27 | Warnings, Adverse reactions | 451W47IQ8X |
| DELFLEX | DEXTROSE MONOHYDRATE, SODIUM CHLORIDE, SODIUM LACTATE, CALCIUM CHLORIDE, MAGNESIUM CHLORIDE | Fresenius Medical Care Renal Therapies Group, LLC | 515dcee0-3e34-11e2-a25f-0800200c9a66 | 2026-07-27 | Warnings, Adverse reactions | 451W47IQ8X |
| Sodium Chloride | SODIUM CHLORIDE | Fresenius Medical Care de Mexico, S.A. de C.V. | 9a1220fb-6853-45ae-838c-10d8596e1af7 | 2026-07-27 | Warnings, Adverse reactions | 451W47IQ8X |
| Sodium Chloride | SODIUM CHLORIDE | Fresenius Medical Care Renal Therapies Group, LLC | af5cdf1a-19f4-11e2-892e-0800200c9a66 | 2026-07-27 | Warnings, Adverse reactions | 451W47IQ8X |
| Levetiracetam Levetiracetam | LEVETIRACETAM | Atlantic Biologicals Corp. | 56fed03f-38c3-4273-8fd7-522bc508bf36 | 2026-07-27 | Warnings, Adverse reactions | 44YRR34555 |
| PEG 3350 and Electrolytes | POLYETHYLENE GLYCOL 3350, SODIUM SULFATE ANHYDROUS, SODIUM BICARBONATE, SODIUM CHLORIDE, POTASSIUM CHLORIDE | A-S Medication Solutions | 19daf830-7270-4661-81b1-ded38f867f28 | 2026-07-24 | Warnings, Adverse reactions | 451W47IQ8X |
| Sterile Water | WATER | Cardinal Health 107, LLC | 9655cd02-82b5-4a75-813b-854b19551481 | 2026-07-21 | Warnings, Adverse reactions | 059QF0KO0R |
| Levetiracetam | LEVETIRACETAM | Cardinal Health 107, LLC | a91defd2-486b-4995-ba4c-640525ab575d | 2026-07-21 | Warnings, Adverse reactions | 44YRR34555 |
| Whisidom Saline Solution | SODIUM CHLORIDE 0.9% SALINE SOLUTION | Jiangxi Yudexi Pharmaceutical Co., LTD | 4e4e4169-2a14-3466-e063-6394a90a081b | 2026-07-20 | Warnings | 451W47IQ8X |
| Saline | NASAL | BEST CHOICE (VALU MERCHANDISERS COMPANY) | 71485e82-bf54-4b8b-8dd2-2a0761534520 | 2026-07-17 | Warnings | 451W47IQ8X |
| Sodium Chloride | SODIUM CHLORIDE | LABORATORIOS GRIFOLS SA | eb811d79-fdb8-1f1a-c2ad-1cc4bfc7eadf | 2026-07-15 | Warnings, Adverse reactions | 451W47IQ8X |
| Levetiracetam | LEVETIRACETAM | REMEDYREPACK INC. | dfc218c5-672a-420a-b59e-2e0b054e99ad | 2026-07-14 | Warnings, Adverse reactions | 44YRR34555 |
| WHWSWB 0.9% SALINE | SODIUM CHLORIDE | Yiwu Huanshu E-commerce Co., Ltd | 5082b773-79b2-2501-e063-6394a90a170f | 2026-07-11 | Warnings | 451W47IQ8X |
| Levetiracetam | LEVETIRACETAM | REMEDYREPACK INC. | ae405796-1eca-4890-bcb2-e1b07654a24d | 2026-07-08 | Warnings, Adverse reactions | 44YRR34555 |
| SALINE NASAL | SODIUM CHLORIDE | ALAINA HEALTHCARE PRIVATE LIMITED | ed30a7f9-7132-42da-9bed-63a9b1c80ab2 | 2026-07-07 | Warnings | 451W47IQ8X |